BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20096774)

  • 1. A pilot study of paternal drug exposure: the Motherisk experience.
    Lee CY; Jin C; Mata AM; Tanaka T; Einarson A; Koren G
    Reprod Toxicol; 2010 Jun; 29(3):353-60. PubMed ID: 20096774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paternal exposure and counselling: experience of a Teratology Information Service.
    De Santis M; Cesari E; Cavaliere A; Ligato MS; Nobili E; Visconti D; Caruso A
    Reprod Toxicol; 2008 Sep; 26(1):42-6. PubMed ID: 18598753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MotherSafe: review of three years of counselling by an Australian Teratology Information Service.
    Lim JM; Sullivan E; Kennedy D
    Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):168-72. PubMed ID: 19432605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of Teratology Information Services (TIS).
    Hancock RL; Koren G; Einarson A; Ungar WJ
    Reprod Toxicol; 2007 Feb; 23(2):125-32. PubMed ID: 17184969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Counselling regarding paternal exposures: Can we do better?
    Ritchie HE; Oakes DJ; Hegedus E; Hill M; Kennedy D
    Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):162-167. PubMed ID: 28276580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of congenital abnormalities in children fathered by men treated with azathioprine or mercaptopurine before conception.
    Nørgård B; Pedersen L; Jacobsen J; Rasmussen SN; Sørensen HT
    Aliment Pharmacol Ther; 2004 Mar; 19(6):679-85. PubMed ID: 15023170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utilization of atypical antipsychotics in pregnancy and lactation.
    Gentile S
    Ann Pharmacother; 2004; 38(7-8):1265-71. PubMed ID: 15150376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using observational cohort data for studying drug effects on pregnancy outcome--methodological considerations.
    Schaefer C; Ornoy A; Clementi M; Meister R; Weber-Schoendorfer C
    Reprod Toxicol; 2008 Sep; 26(1):36-41. PubMed ID: 18588969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs during lactation accenting boron exposure.
    Manakova E; Hubickova-Heringova L; Novakova L
    Neuro Endocrinol Lett; 2008 Oct; 29(5):631-4. PubMed ID: 18987605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paternal exposures and the question of birth defects.
    Poynor DH; Lupkiewicz S; Sage SR; Carver VH; Kousseff BG; Lubs HA; Williams CA
    J Fla Med Assoc; 1997; 84(5):323-6. PubMed ID: 9260438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Counseling regarding pregnancy--related drug exposures by family physicians in Ontario.
    Goodwin J; Rieder S; Rieder MJ; Matsui D
    Can J Clin Pharmacol; 2007; 14(1):e58-69. PubMed ID: 17314415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Consultation activity of two Slovak centres for pharmacotherapy during pregnancy and lactation].
    Tisonová J; Magulová L; Göböová M; Wawruch M; Lassánová M; Bozeková L; Kriska M
    Cas Lek Cesk; 2006; 145(2):154-7; discussion 158-9. PubMed ID: 16521407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A multicenter study of drug use during pregnancy in Spain (IV). The drugs used during lactation. The DUP Working Group Spain].
    Med Clin (Barc); 1992 May; 98(19):726-30. PubMed ID: 1608277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Providing information regarding exposures in pregnancy: a survey of North American Teratology Information Services.
    Hancock RL; Ungar WJ; Einarson A; Goodstadt M; Koren G
    Reprod Toxicol; 2008 Apr; 25(3):381-7. PubMed ID: 18423962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of pregnant women who engage in binge alcohol consumption.
    Gladstone J; Levy M; Nulman I; Koren G
    CMAJ; 1997 Mar; 156(6):789-94. PubMed ID: 9084383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of anti-rheumatic drugs in men trying to conceive: A systematic review and analysis of published evidence.
    Mouyis M; Flint JD; Giles IP
    Semin Arthritis Rheum; 2019 Apr; 48(5):911-920. PubMed ID: 30220537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing treatment access: evaluation of an Australian Web-based alcohol and drug counselling initiative.
    Swan AJ; Tyssen EG
    Drug Alcohol Rev; 2009 Jan; 28(1):48-53. PubMed ID: 19320675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian population.
    Yang T; Walker MC; Krewski D; Yang Q; Nimrod C; Garner P; Fraser W; Olatunbosun O; Wen SW
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):270-7. PubMed ID: 18181228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parental exposure to medications and hydrocarbons and ras mutations in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    Shu XO; Perentesis JP; Wen W; Buckley JD; Boyle E; Ross JA; Robison LL;
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1230-5. PubMed ID: 15247135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.